Skip to content

Clinical trials

Observational Hypersensitivity trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Observational Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20112
20141
20151
20181
20193
20201
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status4
Terminated3
Enrolling by invitation1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre hospitalier de l'Université de Montréal (CHUM)2
University of Calgary2
McGill University1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Nova Scotia Health Authority1
PHAC/CIHR Influenza Research Network1
Sorin Group Canada1
The Hospital for Sick Children1
Toronto Transfusion Medicine Collaborative1
University of British Columbia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity15
Anaphylaxis2
Asthma2
Fibrosis2
Infant, Premature, Diseases2
Non-alcoholic Fatty Liver Disease2
Peri-Implantitis2
Arrhythmias, Cardiac1
Bacterial Infections1
Dermatitis, Contact1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.